查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1197352

IV 極市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)

Iv Poles Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 110 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內，IV 極市場預計將以 6.3% 的複合年增長率增長。

COVID-19 大流行在短期內對市場產生了負面影響，因為早期患者到醫院和診所就診的人數有所下降。 然而，在大流行的後期階段，對研究和臨床試驗的需求增加，以了解靜脈注射和補充劑是否會使受感染患者的 COVID-19 症狀惡化。 例如，NIH 於 2022 年 9 月更新的 COVID-19 治療指南建議，在巴基斯坦一項針對重症 COVID-19 住院患者的開放標籤試驗中，將維生素 C（50 mg/kg/天）添加到標準療法中。當靜脈內給予或隨機接受標準療法（如解熱藥、地塞米鬆或預防性抗生素）時，接受維生素 C 的患者比僅接受標準療法的患者改善更快，住院時間更短。有人提到 因此，大流行期間的這些事件創造了對 IV 治療的需求，從而創造了 IV Pole 市場機會。 因此，由於上述因素和情況，COVID-19 大流行對研究市場產生了重大影響。

癌症、神經系統疾病和胃腸道疾病等慢性病的增加以及老年人口的增加等因素正在促進輸液架市場的增長。

全球人口正在老齡化，最終增加了疾病負擔。 多項研究表明，超過 20% 的老年人口存在維生素 B12 缺乏症的風險。 由於老年人缺乏飲食和營養攝入，維生素缺乏症在 60 歲以上的人群中呈上升趨勢。 例如，根據 BMC Geriatrics 上發表的一篇論文，缺鐵性貧血 (IDA) 是與貧血相關的最常見營養缺乏症，其次是維生素 B12、葉酸和老年人中的鐵。我來了。 上述消息來源還指出，靜脈補鐵可增加血紅蛋白 (Hb) 水平，並減少患有 IDA 的老年手術患者對輸血的需求。 因此，對住院患者有靜脈補劑的需求。

此外，老齡化社會正在快速推進，預計未來還會進一步增加。 例如，根據世界衛生組織2021年10月更新的數據，據說到2030年，全球每6人中就有1人超過60歲。 屆時，60歲以上人口將從2020年的10億增長到14億。 到 2050 年，全球 60 歲及以上人口預計將翻一番，達到 21 億。 因此，老年人口的增長和該人群維生素缺乏症的負擔預計將為靜脈補充劑和維生素創造機會。 預計這將在預測期內創造對 IV 極的需求並推動市場增長。

此外，主要參與者推出的新產品和活動預計將推動市場增長。 例如，2022 年 4 月，FDA 將要求住院成人接受全身性皮質類固醇並需要補充氧氣、無創或有創機械通氣或體外膜肺氧合 (ECMO)。 COVID-19 的治療 因此，這種市場發展預計將產生對 IV 極的需求，用於對患者進行藥物或治療管理，並在預測期內推動市場增長。

因此，由於上述因素，市場有望在預測期內出現增長。 然而，傳統 IV 極帶來的挑戰預計將在預測期內略微阻礙市場增長。

輸液桿市場趨勢

預計在預測期內醫院和診所的銷售額將增長

醫院和診所配備了先進的技術設備來管理患者。 醫療設施的基礎設施發展和新興國家政府組織的支持正在推動 IV 極市場的增長。 此外，患者數量的增加也對該行業產生了積極影響。

此外，輸液架是一種用於固定裝有藥物和液體的輸液袋的裝置。 它被用作醫院的標准設備。 將輸液袋掛在桿頂的掛鉤上。 然後，通過將必要的輸液用管子連接到患者的靜脈，可以安全有效地進行輸液。 這樣，隨著住院病人的增多，輸液架的需求量越來越大，用於靜脈滴註生理鹽水、靜脈注射維生素等各種用途。 例如，根據AIHW 2022年5月公佈的數據，2020-21年澳大利亞住院患者人數約為1180萬，較2019-20年增長6.3%。 在 1180 萬住院患者中，7.0% 是在重症監護病房，3.8% 是因為心血管疾病。 急診和重症監護入院人數的增加產生了對靜脈內補充劑的需求。 因此，上述因素有望推動該分部的增長。

此外，醫院數量的增加是促進該細分市場增長的另一個因素。 根據美國心臟協會發布的統計報告，2020年美國有2946家非政府、非營利性社區醫院，2022年增加到2960家。 醫院數量的增加創造了對醫院輸液架的需求。 因此，預計將推動該板塊的增長。

因此，由於上述因素，預計該細分市場在預測期內將出現增長。

北美預計在預測期內增長

北美目前佔據主要市場份額，預計未來幾年仍將如此。 由於醫療保健支出增加和慢性病負擔增加，預計美國將在其他國家中保持重要的市場份額。

此外，預計美國醫療保健支出的上升趨勢也將推動市場增長。 美國政府和人民每年在醫療保健上花費數百萬美元。 例如，根據經合組織公佈的衛生支出統計數據，美國人均自願醫療費用為1807美元，自付費用醫療費用也有所增加，據報導為每人1225美元。 因此，預計更高的醫療保健支出將增加醫院發展活動和各種慢性病的住院率。 同時，它將推動醫院、診所和其他終端用戶對輸液架的需求。 因此，上述因素有望推動市場增長。

此外，在日本，癌症等慢性病的發病率和患病率正在上升。 根據美國癌症協會的數據，2021 年新發白血病病例估計約為 61,090 例，而 2020 年為 60,530 例。 隨著癌症患者人數的增加，癌症患者的住院和輸液治療次數也將增加，這有望推動市場的增長。

隨著癌症患者的增加，輸液療法的發展在日本不斷進步。 例如，2022 年 8 月，FDA 批准了 Enhertu（famtrastuzumab 和 derquistecan-nxki）用於靜脈輸注作為治療不可切除（unresectionable）或轉移性（metastatic）HER2-low 乳腺癌患者。）”已經獲批。 由於此類治療方法的發展，需要在滴注過程中使用滴液桿。 因此，這有望推動市場增長。

因此，上述因素被認為有助於北美 IV 極市場的增長。

靜脈極市場競爭對手分析

輸電線桿市場競爭適中，由幾家大型企業組成。 目前主導市場的公司包括 3M、Cardinal Health、medifa、Promotal、Alvo、Villard、Antano Group、Savion、Zakad Techniki Medicznej TECH-MED Sp. z o. o.、Besco Medical。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第1章介紹

  • 研究假設和市場定義
  • 調查範圍

第2章研究方法論

第 3 章執行摘要

第4章市場動態

  • 市場概覽
  • 市場驅動因素
    • 消化系統疾病、神經系統疾病和癌症等疾病增加
    • 老年人口增加
  • 市場製約因素
    • 傳統電線桿面臨的挑戰
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：100 萬美元）

  • 按產品類型
    • 2 鉤頂
    • 4 鉤頂
    • 6 鉤頂
    • 8 鉤頂
  • 按材料
    • 不銹鋼
    • 鍍鉻鋼
    • 其他材料
  • 最終用戶
    • 醫院和診所
    • 門診手術中心
    • 其他最終用戶
  • 按地區細分
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 世界其他地區

第6章競爭格局

  • 公司簡介
    • 3M
    • Cardinal Health
    • medifa-hesse GmbH & Co. KG
    • Promotal SAS
    • Villard
    • Antano Group
    • Savion LLC
    • Tech-Med Sp. z.o.o. Department of Medical Technology
    • Besco Medical
    • Bristol Maid
    • COMED
    • Mid Central Medical
    • ALVO Medical

第7章 市場機會與今後動向

簡介目錄
Product Code: 68596

The IV poles market is projected to register a CAGR of 6.3% during the forecast period.

The COVID-19 pandemic had a short-term negative impact on the market due to decreased patient visits to hospitals and clinics in the initial phases. However, during the later phases of the pandemic, the demand for research and clinical trials increased to find out if intravenous (IV) injections and supplements helped escalate the symptoms of COVID-19 in infected patients. For instance, the COVID-19 treatment guideline that the NIH updated in September 2022 mentioned that when patients were randomized to receive IV vitamin C (50 mg/kg per day) with standard therapy or standard therapy such as antipyretics, dexamethasone and prophylactic antibiotics in an open-label trial of hospitalized patients with severe COVID-19 in Pakistan, those who got vitamin C experienced earlier symptom remission and shorter hospital stays than those who just received standard therapy. Thus, these instances during the pandemic created a demand for IV treatments, ultimately generating opportunities for the IV poles market. Therefore, owing to the abovementioned factors and instances, the COVID-19 pandemic significantly impacted the market studied.

Factors like increasing chronic diseases, such as cancer, neurological diseases, and gastrointestinal disorders, and an increase in the geriatric population contribute to the growth of the IV poles market.

The population is aging globally, ultimately increasing the disease burden. Various research suggests that more than 20% of the geriatric population is at risk of vitamin B12 deficiency. Due to insufficient intake of food and nutrition at an older age, vitamin deficiency increases among the elderly population aged 60 years or more. For instance, according to an article published in the BMC Geriatrics journal, iron deficiency anemia (IDA) is the most common type of nutrient deficit linked with anemia, followed by vitamin B12, folate, and iron in the older population. Additionally, the above source also stated that, in elderly surgical patients with IDA, intravenous iron supplementation raises hemoglobin (Hb) levels and lowers the need for blood transfusions. Thus, there is a demand for IV supplements among hospitalized patients.

In addition, the aging population is increasing rapidly, and it is expected to increase more quickly in the future. For instance, the data updated by the WHO in October 2021 shows that one in six individuals will be 60 or older by 2030 globally. By this time, there will be 1.4 billion people over 60, up from 1 billion in 2020. The number of people around the globe who are 60 years or older will double to 2.1 billion by 2050. Thus, the increasing geriatric population, coupled with the burden of vitamin deficiency among this population, is expected to create opportunities for IV supplements and vitamins. This is projected to generate demand for IV poles, thus driving the growth of the market over the forecast period.

Furthermore, the introduction of new products and activities by major players is predicted to fuel the growth of the market. For instance, in April 2022, the FDA granted priority review to Genentech's Actemra (tocilizumab) intravenous (IV) for the treatment of COVID-19 in hospitalized adults receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO). Thus, such developments are expected to generate demand for IV poles for drug or therapy administration to patients and drive the growth of the market over the forecast period.

Therefore, the market is expected to witness growth over the forecast period due to the factors mentioned above. However, the challenges faced by conventional IV poles are anticipated to hamper the growth of the market slightly during the forecast period.

IV Poles Market Trends

The Hospitals and Clinics Segment is Expected to Witness Growth During the Forecast Period

Hospitals and clinics are well-equipped with advanced technological equipment for patient management. The improving infrastructure of healthcare facilities in emerging economies and support from government organizations fuel the growth of the segment in the IV poles market. Furthermore, the increasing pool of patients also has a positive effect on this segment.

Additionally, IV poles are equipment that hold IV bags filled with medicine or fluid in place. They are a standard component of hospital operations. The hooks at the top of the pole are used to hang the bags. The necessary fluids are then securely and effectively delivered by connecting them via a tube into the patient's veins. Thus, with increasing numbers of hospital admissions, the demand for IV poles is growing for various applications, such as IV saline and IV vitamin therapy. For instance, according to the data published by the AIHW in May 2022, about 11.8 million hospital admissions occurred in Australia in 2020-21, which is 6.3% more compared to 2019-20. It also reported that out of 11.8 million admissions, 7.0% of hospitalizations involved a stay in the intensive care unit, and 3.8% of hospitalizations involved cardiovascular disease. Such increasing admissions to emergency and critical care generate the need for IV supplements. Thus, the abovementioned factors are expected to drive the growth of the segment.

Furthermore, the increasing number of hospitals is another factor that contributes to the growth of the segment. According to the statistics report published by the AHA, there were 2,946 non-government, not-for-profit community hospitals in the United States in 2020, which increased to 2,960 in 2022. This increase in the number of hospitals creates a demand for IV poles in hospital settings. Hence, it is expected to boost the growth of the segment.

Therefore, owing to the abovementioned factors, the segment is expected to witness growth over the forecast period.

North America is Expected to Witness Growth During the Forecast Period

North America currently holds a major market share, and it is expected to continue its stronghold for a few more years. The United States is expected to retain its significant market share among other countries, owing to rising healthcare expenditure and the increasing burden of chronic diseases.

The increasing trend of rising healthcare expenditures in the United States is also predicted to propel market growth. The US government and the population spend a significant amount on healthcare every year. For instance, the health spending statistics published by the OECD reported that in the United States, voluntary healthcare spending per capita accounted for USD 1,807, and out-of-pocket spending on healthcare also increased, which accounted for USD 1,225 per capita. Thus, high expenditure on healthcare is anticipated to increase hospital development activities and hospital admissions for various chronic diseases. Simultaneously, it will generate demand for IV poles used in hospitals, clinics, and other end users. Therefore, the abovementioned factors are expected to drive the growth of the market.

Furthermore, the incidence and prevalence of chronic diseases like cancer are increasing in the country. According to the American Cancer Society, there were around 61,090 new estimated cases of leukemia in 2021, compared to 60,530 in 2020. As cancer cases increase, hospital admissions and IV therapies for cancer patients will also increase, driving the growth of the market.

With the increase in cancer cases, the development of IV therapies is also increasing in the country. For instance, in August 2022, the FDA approved Enhertu (fam-trastuzumab-deruxtecan-nxki), an IV infusion, for the treatment of patients with unresectable (unable to be removed) or metastatic (spread to other parts of the body) HER2-low breast cancer. This development of therapies is creating demand for the availability of IV poles used during infusion. Hence, this is expected to fuel the growth of the market.

Therefore, the abovementioned factors are expected to contribute to the growth of the market for IV poles in North America.

IV Poles Market Competitor Analysis

The IV Poles market is moderately competitive and consists of several major players. Some companies that are currently dominating the market are 3M, Cardinal Health, medifa, Promotal, Alvo, Villard, Antano Group, Savion, Zakad Techniki Medycznej TECH-MED Sp. z o. o., and Besco Medical.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Diseases, such as Gastrointestinal Disorder, Neurological Diseases, Cancer
    • 4.2.2 Increasing Geriatric Population
  • 4.3 Market Restraints
    • 4.3.1 Challenges Faced by The Conventional Poles
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product Type
    • 5.1.1 2 Hook Top
    • 5.1.2 4 Hook Top
    • 5.1.3 6 Hook Top
    • 5.1.4 8 Hook Top
  • 5.2 By Material
    • 5.2.1 Stainless Steel
    • 5.2.2 Chrome-plated Steel
    • 5.2.3 Other Materials
  • 5.3 By End User
    • 5.3.1 Hospitals and Clinics
    • 5.3.2 Ambulatory Surgical Centers
    • 5.3.3 Other End Users
  • 5.4 By Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Rest of the World

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 3M
    • 6.1.2 Cardinal Health
    • 6.1.3 medifa-hesse GmbH & Co. KG
    • 6.1.4 Promotal SAS
    • 6.1.5 Villard
    • 6.1.6 Antano Group
    • 6.1.7 Savion LLC
    • 6.1.8 Tech-Med Sp. z.o.o. Department of Medical Technology
    • 6.1.9 Besco Medical
    • 6.1.10 Bristol Maid
    • 6.1.11 COMED
    • 6.1.12 Mid Central Medical
    • 6.1.13 ALVO Medical

7 MARKET OPPORTUNITIES AND FUTURE TRENDS